ASNRT — Arab Society of Nephrology and Renal Transplantation

النسخة العربية من هذه الصفحة

Anti-glomerular basement membrane disease-treatment standard.

A 2025 practice review from the European Renal Association outlines current anti-GBM disease treatment standards - plasma exchange, cyclophosphamide, and steroids - while highlighting open questions about rituximab and emerging agents like imlifidase.

Category

Transplant

Source

Nephrology Dialysis Transplantation

Read the original article

More from ASNRT News

Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.

All news · ASNRT home